Moracizine

Moracizine also known as moricizine is an antiarrhythmic of class IC. It was used for the prophylaxis and treatment of serious and life-threatening ventricular arrhythmias  moracizine was equally or more effective in suppressing premature ventricular contractions, couplets, and nonsustained ventricular tachycardia

Moracizine, also known by the trade name Ethmozine, was a medication belonging to the class IC antiarrhythmics. It was primarily used to treat and prevent serious irregular heartbeats known as ventricular arrhythmias. 

However, it's important to note that Moracizine was withdrawn from the market in 2007 solely for commercial reasons, not due to safety or efficacy concerns.

Here's a summary of what Moracizine was:

  • Type of drug: Antiarrhythmic (Class IC)
  • Function: Regulates heart rhythm by acting on heart muscle cells
  • Applications: Treatment and prevention of ventricular arrhythmias
  • Current status: Withdrawn from the market (2007)

It's crucial to remember that Moracizine is no longer a commercially available medication. If you have any concerns about your heart rhythm, please consult a qualified healthcare professional for proper diagnosis and treatment. They can recommend alternative medications that are currently approved and effective for managing arrhythmias.

Anatomical Therapeutic Chemical Classification
C - Cardiovascular system
C01 Cardiac therapy
C01B - Antiarrhythmics, class I and III
C01BG Other antiarrhythmics, class I and III
External Links